Mandy Boer

Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands ; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article and Find Full Text PDF

December 2013

MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.

Authors:

Vassiliki Theodorou Melanie A Kimm Mandy Boer Lodewyk Wessels Wendy Theelen Jos Jonkers John Hilkens

Nat Genet 2007 Jun 29;39(6):759-69. Epub 2007 Apr 29.

Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article and Find Full Text PDF

June 2007

Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.

Authors:

Vassiliki Theodorou Mandy Boer Britta Weigelt Jos Jonkers Martin van der Valk John Hilkens

Oncogene 2004 Aug;23(36):6047-55

Division of Tumor Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article and Find Full Text PDF

August 2004

Publications by authors named "Mandy Boer"

Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.

Authors:

IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation.

Authors:

RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.

Authors:

Analysis of tumor heterogeneity and cancer gene networks using deep sequencing of MMTV-induced mouse mammary tumors.

Authors:

MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.

Authors:

Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.

Authors: